Local Institution - 011 — New York, New York

Local Institution - 011 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 011 has participated in 2 clinical trials.

Therapeutic areas: Eosinophilic Esophagitis, Multiple Myeloma.

Sponsors: Celgene, Juno Therapeutics, a Subsidiary of Celgene.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 011?

Local Institution - 011 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 011 conducted?

Local Institution - 011 has 2 clinical trials on record. Their work covers Eosinophilic Esophagitis, Multiple Myeloma.

Is Local Institution - 011 accredited by Crixeo Health?

Local Institution - 011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 011?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.